Billions of dollars and innovative partnership models are needed to accelerate the development and deployment of tools with which to fight neglected infectious and emerging disease, globally and specifically in the poorest countries. COVID-19 is a stark reminder of health and economic consequence of not acting, of not investing in innovation.

As many G20 countries explore how to expand and combine government and industry investments to achieve the goals of accelerated tool development and deployment, the Japanese Global Health Innovative Technology Fund (GHIT Fund) and the recently established Korean initiative, the Research Investment for Global Health Technology Fund (RIGHT Fund), are important models from which to learn.

Panorama, in partnership with Hannah E. Kettler, PhD, drafted a report on the GHIT Fund’s model and the impact it is having on global health research & development, and explores what the lessons learned from the GHIT and RIGHT Funds suggest about the potential replicability of the model in other settings.